Sep 15, 2020
New iCIEF System and Two Biopharma Customer Seminars Highlight Intabio's Momentum at 22nd Symposium of CE Pharm
Sep 01, 2020
Intabio Joins 17th Symposium on Mass Spectrometry with Podium Presentation from Merck Highlighting iCIEF-MS Applications for Forced Degradation Studies
Aug 11, 2020
Intabio Signs Co-Marketing Agreement with Agilent Technologies Inc. to Support Development of Integrated iCIEF-MS Assay
Jun 16, 2020
Intabio launches Blaze(TM) System to accelerate biotherapeutic development
May 07, 2020
Intabio announces new website and digital marketing strategy to support Blaze(TM) system commercial launch
Mar 11, 2020
Intabio and Protein Metrics Launch Strategic Partnership
Feb 06, 2020
Intabio Closes $18 Million Round in Series B Funding to Build Commercial Team and Launch Blaze(TM) Platform
Jan 07, 2020
Intabio Announces Seminal Publication Describing Blaze(TM) Technology for Comprehensive Biopharmaceutical Product Quality Analysis
Jun 03, 2019
Intabio to Present Groundbreaking Innovation in Therapeutic Antibody Quality Characterization at ASMS Conference
Feb 26, 2019
Rohit Khanna Joins Intabio's Board of Directors
Jan 22, 2019
Intabio to Present Latest Advance in Biopharmaceutical Quality Characterization at WCBP Conference
Oct 30, 2018
Intabio Raises $9.5 Million in Series A Financing
Aug 15, 2018
Intabio Awarded $2.3 Million SBIR Fast Track Grant to Support Commercial Development of a Novel Microchip-based Solution for Biopharmaceutical Analysis
Jun 13, 2018
Intabio to Collaborate with Bruker on Novel Interface For Bruker's UHR-QTOF Mass Spectrometers
Sep 14, 2017
Intabio Announces $2M Seed Financing